Development of poly(hydroxyethyl methacrylate) nanogel for effective oral insulin delivery

References

• Arbit E. 2004. The physiological rationale for oral insulin administration. Diabetes Technol Ther. 6:510–517.
   PubMedGoogle Scholar
• Awoniyi O, Rehman R, Dagogo-Jack S. 2013. Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention. Curr Diab Rep. 13:669–678.
   PubMed Web of Science ®Google Scholar
• Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P. 1982. Absorption kinetics and biologic effects of subcutaneously injected insulin preparation. Diabetes Care. 5:77–91.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Gunn J, Zhang M. 2010. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev. 62:83–99.
   PubMed Web of Science ®Google Scholar
• Calvo P, Gouritin B, Brigger I, Lasmezas C, Deslys J, Williams A, Andreux JP, Dormont D, Couvreur P. 2001. PEGylated polycyanoacrylate nanoparticles as a vector for drug delivery in prion diseases. J Neurosci Methods. 111:151–155.
   PubMed Web of Science ®Google Scholar
• Chou DH, Webber MJ, Tang BC, Lin AB, Thapa LS, Deng D, Truong JV, Cortinas AB, Langer R, Anderson DG. 2015. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proc Natl Acad Sci USA. 112:2401–2406.
   PubMed Web of Science ®Google Scholar
• Crane CW, Luntz GR. 1968. Absorption of insulin from the human small intestine. Diabetes. 17:625–627.
   PubMed Web of Science ®Google Scholar
• Déat-Lainé E, Hoffart V, Garrait G, Jarrige JF, Cardot JM, Subirade M, Beyssac E. 2013. Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery. Pharm Res. 30:721–734.
   PubMed Web of Science ®Google Scholar
• Hecq J, Siepmann F, Siepmann J, Amighi K, Goole J. 2015. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration. Drug Dev Ind Pharm. 41:2037–2044.
   PubMed Web of Science ®Google Scholar
• Jain AK, Chalasani KB, Khar RK, Ahmed FJ, Diwan PV. 2007. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target. 15:417–427.
   PubMed Web of Science ®Google Scholar
• Lima EG, Durney KM, Sirsi SR, Nover AB, Ateshian GA, Borden MA, Hung CT. 2012. Microbubbles as biocompatible porogens for hydrogel scaffolds. Acta Biomater. 8:4334–4341.
   PubMed Web of Science ®Google Scholar
• Liu Z, Davis C, Cai W, He L, Chen X, Dai H. 2008. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA. 105:1410–1415.
   PubMed Web of Science ®Google Scholar
• Madsen F, Peppas NA. 1999. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials. 20:1701–1708.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, Ostad SN, Rafiee-Tehrani M. 2014. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm. 40:1645–1659.
   PubMed Web of Science ®Google Scholar
• Morishita M, Lowman AM, Takayama K, Nagai T, Peppas NA. 2002. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release. 81:25–32.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Chakraborty S, Bhattacharya S, Mishra R, Kundu PP. 2015. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol. 72:640–648.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Rangaswamy V, Aminabhavi TM. 2011. pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm. 37:977–985.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. 2003. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 55:403–419.
   PubMed Web of Science ®Google Scholar
• Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. 2009. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9:1909–1915.
   PubMed Web of Science ®Google Scholar
• Prencipe G, Tabakman SM, Welsher K, Liu Z, Goodwin AP, Zhang L, Henry J, Dai H. 2009. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc. 131:4783–4787.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R. 2007a. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 8:3054–3060.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. 2007b. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 24:2198–2206.
   PubMed Web of Science ®Google Scholar
• Siegwart DJ, Srinivasan A, Bencherif SA, Karunanidhi A, Oh JK, Vaidya S, Jin R, Hollinger JO, Matyjaszewski K. 2009. Cellular uptake of functional nanogels prepared by inverse miniemulsion ATRP with encapsulated proteins, carbohydrates, and gold nanoparticles. Biomacromolecules. 10:2300–2309.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Ryckman KK. 2015. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab Syndr Obes. 8:295–302.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Kawashima Y, Xia D, Cui F. 2011. Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomedicine. 6:3049–3056.
   PubMed Web of Science ®Google Scholar
• Venugopal J, Prabhakaran MP, Low S, Choon AT, Zhang YZ, Deepika G, Ramakrishna S. 2008. Nanotechnology for nanomedicine and delivery of drugs. Curr Pharm Des. 14:2184–2200.
   PubMed Web of Science ®Google Scholar
• von Bibra H, Paulus WJ, St John Sutton M, Leclerque C, Schuster T, Schumm-Draeger PM. 2015. Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes. Int J Cardiol. 182:368–374.
   PubMed Web of Science ®Google Scholar
• Wang G, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE, Banda NK, Simberg D. 2014. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. ACS Nano. 8:12437–12449.
   PubMed Web of Science ®Google Scholar
• Xiao W, Lin J, Li M, Ma Y, Chen Y, Zhang C, Li D, Gu H. 2012. Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents. Contrast Media Mol Imaging. 7:320–327.
   PubMed Web of Science ®Google Scholar
• Yan M, Ge J, Liu Z, Ouyang P. 2006. Encapsulation of single enzyme in nanogel with enhanced biocatalytic activity and stability. J Am Chem Soc. 128:11008–11009.
   PubMed Web of Science ®Google Scholar
• Yaturu S. 2013. Insulin therapies: current and future trends at dawn. World J Diabetes. 4:1–7.
   PubMedGoogle Scholar
• Zhang L, Cao Z, Bai T, Carr L, Ella-Menye JR, Irvin C, Ratner BD, Jiang S. 2013. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol. 31:553–556.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao Z, Li Y, Ella-Menye JR, Bai T, Jiang S. 2012. Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. ACS Nano. 6:6681–6686.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xue H, Cao Z, Keefe A, Wang J, Jiang S. 2011. Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance. Biomaterials. 32:4604–4608.
   PubMed Web of Science ®Google Scholar
• Zhou J, Beattie DA, Ralston J, Sedev R. 2007. Colloid stability of thymine-functionalized gold nanoparticles. Langmuir. 23:12096–12103.
   PubMed Web of Science ®Google Scholar